Cecilia Lindestam Arlehamn

Immunology - T cells - Tuberculosis - Neurodegenerative diseases

[Cecilia Lindestam Arlehamn @arlehamn]

Join us in Stockholm 4-6th of September for Mycobact2024
Abstract deadline on June 21st!
https://t.co/BsXHHd4L95

[Cecilia Lindestam Arlehamn @arlehamn]

A fantastic meeting as always! @ljiresearch @Tom_Riffel

[Olivier Neyrolles @ONeyrolles]

Yet another fantastic #CTVD meeting!
@gatesfoundation⁩

[Cecilia Lindestam Arlehamn @arlehamn]

Join us in Stockholm in September!
https://t.co/bPMXjTjRIE

[La Jolla Institute @ljiresearch]

New #tuberculosis research review from LJI Research Assistant Professor Cecilia Lindestam Arlehamn (@arlehamn) and LJI colleagues:

"From antigens to immune responses: Shaping the future of TB detection and prevention." https://t.co/tFvxMAnm5t

#GlobalHealth #TB #VaccineResearch

[Cecilia Lindestam Arlehamn @arlehamn]

#WorldTBDay2024 and the start of the #TBKeystone looking forward to this conference! @ljiresearch @sudhasinipanda

[VALIDATE Network @NetworkValidate]

Sunday is #WorldTBDay 2024. The End TB Alliance have some excellent social media resources.

[Cecilia Lindestam Arlehamn @arlehamn]

Our new pre-print is online! https://t.co/cnfqHf6Q2d
T cells from patients with PD recognize PINK1 as an autoantigen
@ljiresearch @SetteLab

[Cecilia Lindestam Arlehamn @arlehamn]

The peptide pool was validated in two independent, geographically different cohorts and showed high sensitivity and specificity for distinguishing patient groups.

[Cecilia Lindestam Arlehamn @arlehamn]

Proud to share our latest publication in Nature Communications https://t.co/6HK924Akr2
@ljiresearch @sudhasinipanda @bpeters @SetteLab

[Cecilia Lindestam Arlehamn @arlehamn]

While there is a lot of overlap, as expected, we describe a peptide pool primarily reactive in patients with ATB (both at diagnosis and mid-treatment).

[La Jolla Institute @ljiresearch]

Researchers find new links between #Tcell exhaustion and #Alzheimers — with contributions from LJI's @SetteLab and @arlehamn

https://t.co/RxoezZbizp

#Immunology #Neuroinflammation #Aging #Neuroscience #ImmuneCells @SciReports

[Cecilia Lindestam Arlehamn @arlehamn]

@w_mcewan Congrats to both 🥳🥂

[Cecilia Lindestam Arlehamn @arlehamn]

I'm also looking forward to this workshop 👇!
See you there?
@ljiresearch

[Paul Ogongo @JaTcells]

Looking forward to this workshop next month. Register and join us in the discussion. Book your seat by following this link. https://t.co/r2bN4Ir0gw

[Cecilia Lindestam Arlehamn @arlehamn]

Great job, @sudhasinipanda

[Sudha @sudhasinipanda]

Amazing opportunity to talk about our work at #AAI2023 at poster session.
#LJI #tuberculosis

[Cecilia Lindestam Arlehamn @arlehamn]

Promising TB vaccine candidate! Excited to have played a small part in this study.

[Rasmus Mortensen @RMortensen_SSI]

Imagine if subunit vaccines should be given only once! Check out our latest paper describing how BCG and our new TB vaccine candidate synergize to be efficacious after a single dose compared to traditional prime-boost! Thanks to all for the hard work! https://t.co/QQfD4TmzIZ

[Rasmus Mortensen @RMortensen_SSI]

Imagine if subunit vaccines should be given only once! Check out our latest paper describing how BCG and our new TB vaccine candidate synergize to be efficacious after a single dose compared to traditional prime-boost! Thanks to all for the hard work! https://t.co/QQfD4TmzIZ

[Cecilia Lindestam Arlehamn @arlehamn]

Such a pleasure visiting collaborators in Kenya.

[Cecilia Lindestam Arlehamn @arlehamn]

Hot off the press! Approaches to studying antigen-specific T cells and their TCR repertoire.
https://t.co/UIk5cMorOt
A pleasure to work with these talented scientists! #WomenInSTEM @ljiresearch @sudhasinipanda @sloanlewis @kendallk_13 @LYChihab